These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 35989064)

  • 21. Interstitial pneumonitis after COVID-19 vaccination: A report of three cases.
    Shimizu T; Watanabe S; Yoneda T; Kinoshita M; Terada N; Kobayashi T; Gohara K; Tsuji T; Nakatsumi H; Tambo Y; Ohkura N; Abo M; Hara J; Sone T; Kimura H; Kasahara K
    Allergol Int; 2022 Apr; 71(2):251-253. PubMed ID: 34772608
    [No Abstract]   [Full Text] [Related]  

  • 22. COVID-19 mRNA Vaccine-induced Pneumonitis.
    Matsuzaki S; Kamiya H; Inoshima I; Hirasawa Y; Tago O; Arai M
    Intern Med; 2022 Jan; 61(1):81-86. PubMed ID: 34707048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of severe interstitial lung disease after COVID-19 vaccination.
    Kono A; Yoshioka R; Hawk P; Iwashina K; Inoue D; Suzuki M; Narita C; Haruta K; Miyake A; Yoshida H; Tosaka N
    QJM; 2022 Jan; 114(11):805-806. PubMed ID: 34618126
    [No Abstract]   [Full Text] [Related]  

  • 24. COVID-19 vaccine induced interstitial lung disease.
    Yoshifuji A; Ishioka K; Masuzawa Y; Suda S; Murata S; Uwamino Y; Fujino M; Miyahara H; Hasegawa N; Ryuzaki M; Hoshino H; Sekine K
    J Infect Chemother; 2022 Jan; 28(1):95-98. PubMed ID: 34580010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective.
    Niebel D; Novak N; Wilhelmi J; Ziob J; Wilsmann-Theis D; Bieber T; Wenzel J; Braegelmann C
    Vaccines (Basel); 2021 Aug; 9(9):. PubMed ID: 34579181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines.
    Rijkers GT; Weterings N; Obregon-Henao A; Lepolder M; Dutt TS; van Overveld FJ; Henao-Tamayo M
    Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34451973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
    Barda N; Dagan N; Ben-Shlomo Y; Kepten E; Waxman J; Ohana R; Hernán MA; Lipsitch M; Kohane I; Netzer D; Reis BY; Balicer RD
    N Engl J Med; 2021 Sep; 385(12):1078-1090. PubMed ID: 34432976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in respiratory virus infection trends during the COVID-19 pandemic in South Korea: the effectiveness of public health measures.
    Park JY; Kim HI; Kim JH; Park S; Hwang YI; Jang SH; Kim YK; Jung KS
    Korean J Intern Med; 2021 Sep; 36(5):1157-1168. PubMed ID: 34399570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 vaccine-related interstitial lung disease: a case study.
    Park JY; Kim JH; Lee IJ; Kim HI; Park S; Hwang YI; Jang SH; Jung KS
    Thorax; 2022 Jan; 77(1):102-104. PubMed ID: 34362838
    [No Abstract]   [Full Text] [Related]  

  • 30. Myocarditis With COVID-19 mRNA Vaccines.
    Bozkurt B; Kamat I; Hotez PJ
    Circulation; 2021 Aug; 144(6):471-484. PubMed ID: 34281357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia.
    Huynh A; Kelton JG; Arnold DM; Daka M; Nazy I
    Nature; 2021 Aug; 596(7873):565-569. PubMed ID: 34233346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
    Greinacher A; Thiele T; Warkentin TE; Weisser K; Kyrle PA; Eichinger S
    N Engl J Med; 2021 Jun; 384(22):2092-2101. PubMed ID: 33835769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: a nationwide claims study.
    Huh K; Kim YE; Ji W; Kim DW; Lee EJ; Kim JH; Kang JM; Jung J
    Thorax; 2021 Sep; 76(9):939-941. PubMed ID: 33782081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.
    Vojdani A; Vojdani E; Kharrazian D
    Front Immunol; 2020; 11():617089. PubMed ID: 33584709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans.
    Cagigi A; Loré K
    Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33477534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper From the Fleischner Society.
    Johkoh T; Lee KS; Nishino M; Travis WD; Ryu JH; Lee HY; Ryerson CJ; Franquet T; Bankier AA; Brown KK; Goo JM; Kauczor HU; Lynch DA; Nicholson AG; Richeldi L; Schaefer-Prokop CM; Verschakelen J; Raoof S; Rubin GD; Powell C; Inoue Y; Hatabu H
    Chest; 2021 Mar; 159(3):1107-1125. PubMed ID: 33450293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
    Voysey M; Clemens SAC; Madhi SA; Weckx LY; Folegatti PM; Aley PK; Angus B; Baillie VL; Barnabas SL; Bhorat QE; Bibi S; Briner C; Cicconi P; Collins AM; Colin-Jones R; Cutland CL; Darton TC; Dheda K; Duncan CJA; Emary KRW; Ewer KJ; Fairlie L; Faust SN; Feng S; Ferreira DM; Finn A; Goodman AL; Green CM; Green CA; Heath PT; Hill C; Hill H; Hirsch I; Hodgson SHC; Izu A; Jackson S; Jenkin D; Joe CCD; Kerridge S; Koen A; Kwatra G; Lazarus R; Lawrie AM; Lelliott A; Libri V; Lillie PJ; Mallory R; Mendes AVA; Milan EP; Minassian AM; McGregor A; Morrison H; Mujadidi YF; Nana A; O'Reilly PJ; Padayachee SD; Pittella A; Plested E; Pollock KM; Ramasamy MN; Rhead S; Schwarzbold AV; Singh N; Smith A; Song R; Snape MD; Sprinz E; Sutherland RK; Tarrant R; Thomson EC; Török ME; Toshner M; Turner DPJ; Vekemans J; Villafana TL; Watson MEE; Williams CJ; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ;
    Lancet; 2021 Jan; 397(10269):99-111. PubMed ID: 33306989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    Polack FP; Thomas SJ; Kitchin N; Absalon J; Gurtman A; Lockhart S; Perez JL; Pérez Marc G; Moreira ED; Zerbini C; Bailey R; Swanson KA; Roychoudhury S; Koury K; Li P; Kalina WV; Cooper D; Frenck RW; Hammitt LL; Türeci Ö; Nell H; Schaefer A; Ünal S; Tresnan DB; Mather S; Dormitzer PR; Şahin U; Jansen KU; Gruber WC;
    N Engl J Med; 2020 Dec; 383(27):2603-2615. PubMed ID: 33301246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Exclusion of Older Persons From Vaccine and Treatment Trials for Coronavirus Disease 2019-Missing the Target.
    Helfand BKI; Webb M; Gartaganis SL; Fuller L; Kwon CS; Inouye SK
    JAMA Intern Med; 2020 Nov; 180(11):1546-1549. PubMed ID: 32986099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-Induced Interstitial Lung Disease: A Systematic Review.
    Skeoch S; Weatherley N; Swift AJ; Oldroyd A; Johns C; Hayton C; Giollo A; Wild JM; Waterton JC; Buch M; Linton K; Bruce IN; Leonard C; Bianchi S; Chaudhuri N
    J Clin Med; 2018 Oct; 7(10):. PubMed ID: 30326612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.